Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: A serologic study of 46 patients;Gli anticorpi miosite specifici e miosite associati nelle miopatie infiammatorie idiopatiche: Studio sierologico di 46 pazienti

Reumatismo

Volumn 57, Issue 1, 2005, Pages 22-28

  Ghirardello, A ^a   Zampieri, S ^a   Iaccarino, L ^a   Tarricone, E ^a   Tonello, M ^a   Bendo, R ^a   Rondinone, R ^a   Cozzi, F ^a   Doria, Andrea ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Immunoblotting; Mi 2; Myositis; RNA immunoprecipitation; tRNA synthetase

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; JO 1 ANTIBODY; KU ANTIGEN; MI 2 ANTIBODY; RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; DERMATOMYOSITIS; DIAGNOSTIC VALUE; HUMAN; IMMUNOBLOTTING; IMMUNOELECTROPHORESIS; IMMUNOPRECIPITATION; MYOSITIS; POLYMYOSITIS; PROGNOSIS; SEROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOSITIS; SEROLOGIC TESTS;

EID: 15944368128     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bohan A. Peter JB. Polymyositis and dermatomyositis. New Engl J Med 1975; 13: 344-6.
2. Dalakas MC. Polymyositis, dermatomyositis and inclusion body myositis. N Eng J Med 1991; 325: 1487-98.
3. Euwer RL, Sontheimer RD. Dermatologic aspects of myositis. Curr Opin Rheumatol 1994; 6: 583-9.
4. Rockerbie NR, Woo TY, Callen JP, Giustina T. Cutaneous changes of dermatomyositis precede muscle weakness. J Am Acad Dermatol 1989; 20: 629-32.
5. Brouwer R, Hengstman GJ, Vree Egberts W, Ehrfeld H, Bozic B, Ghirardello A, et al. Autoantibodies profiles in the sera of European patients with myositis. Ann Rheum Dis 2001; 60: 116-23.
6. Franceschini F, Cavazzana I, Generali D, Quinzanini M, Viardi L, Ghirardello A, et al. Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients. J Rheumatol 2002; 29: 1393-7.
7. Rutjes SA, Vree Egberts WTM, Jongen P, van den Hoogen F, Prujin GJM, van Venrooij WJ. Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy. Clin Exp Immunol 1997; 109: 32-40.
8. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991; 70: 360-74.
9. Plotz PH, Rider LG, Targoff IN, Raben N, O'Hanlon TP, Miller FW. NIH conference. Myositic immunologic contributions to understanding cause, pathogenesis and therapy. Ann Intern Med 1995; 122: 715-24.
10. Targoff IN. Immune manifestations of inflammatory muscle disease. Rheum Dis Clin North Am 1994; 20: 857-80.
11. Zampieri S, Ghirardello A, Rossini K, Iaccarino L, Gambari PF, Doria A. Autoantibodies in idiopathic inflammatory myopathies. Basic Appl Myol 2002; 12: 27-31.
12. Targoff IN, Miller FW, Medsger TA Jr, Oddis CV. Classification criteria for the idiopathic inflammatory myopathies. Curr Opin Rheumatol 1997; 9: 527-35.
13. Hengstman GJ, Brouwer R, Egberts WT, Seelig HP, Jongen PJ, van Venrooij WJ, et al. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies. J Neurol 2002; 249: 69-75.
14. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population based study. Lancet 2001; 357: 96-100.
15. Bunn CC, Gharavi AE, Hughes GRV. Antibodies to extractable nuclear antigens in 173 patients with DNA-binding positive SLE: association between antibodies to ribonuclear protein and Sm antigens observed by counterimmunoelectrophoresis. J Clin Lab Immunol 1982; 8: 13-20.
16. Ghirardello A, Doria A, Zampieri S, Gerli R, Rapizzi E, Gambari P.F. Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies. Ann Rheum Dis 2000; 59: 875-81.
17. Ghirardello A, Doria A, Vesco P, Vaccaro E, Bernardi C, Catani C, et al. Blotting patterns of IgG anti-(U1)RNP antibodies in mixed connective tissue disease. Rheumatol Int 1996; 16: 145-50.
18. Zampieri S, Ghirardello A, Doria A, Tonello M, Bendo R, Rossini K, et al. The use of Tween 20 in immunoblotting assays for the detection of autoantibodies in connective tissue diseases. J Immunol Methods 2000; 239: 1-11.
19. Forman MS, Nakamura M, Mimori T, Gelpi C, Hardin J. Detection of antibodies to small nuclear ribonucleoproteins and small ribonucleoproteins using unlabeled extracts. Arthritis Rheum 1985; 28: 1356-61.
20. Zampieri S, Degen W, Ghirardello A, Doria A, van Venrooij WJ. Dephosphorylation of autoantigenic ribosomal P proteins during Fas-L induced apoptosis: a possible trigger for the development of the autoimmune response in patients with systemic lupus erythematosus. Ann Rheum Dis 2001; 60: 72-6.
21. Merril C, Goldman D, Sedman S, Ebert M. Ultrasensitive stain for proteins in polyacrylamide gels shows regional variations in cerebrospinal fluid proteins: Science 1981; 211: 1437-8.
22. Salviati G, Betto R, Danieli Betto D. Polymorphism of myofibrillar proteins of rabbit skeletal-muscle fibers. An electrophoretic study of single fibers. Biochem J 1982; 207: 261-72.
23. Reichlin M, Arnett Jr FC. Multiplicity of antibodies in myositis sera. Arthritis Rheum 1984; 27: 1150-6.
24. Imbert-Masseau A, Hamidou M, Agard C, Grolleau J-Y, Cherin P. Antisynthetase syndrome. Joint Bone Spine 2003; 70: 161-8.
25. Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK, et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 1990; 77: 1019-38.
26. Seelig HP, Moosbrugger I, Ehrfeld H, Fink T, Renz M, Genth E. The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation. Arthritis Rheum 1995; 38: 1389-99.
27. Zheng Y, LeRoy G, Seelig HP, Lane WS, Reinberg D. The dermatomyositis-specific autoantigen Mi-2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell 1998; 95: 279-89.
28. Nilasena DS, Trieu EP, Targoff IN. Analysis of the Mi-2 autoantigen of dermatomyositis. Arthritis Rheum 1995; 123-8.
29. Ge Q, Nilasena DS, O'Brien CA, Frank MB, Targoff IN. Molecular analysis of a major antigenic region of the 240-Kd protein of Mi-2 autoantigen. J Clin Invest 1995; 96: 1730-7.
30. Targoff IN, Reichlin M. The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum 1985; 28: 796-803.